Browsing by Author Tang, Hai
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2013 | Alendronate Sodium/Vitamin D Combination Tablet versus Calcitriol for Osteoporosis in Chinese Postmenopausal Women: A 6-Month, Randomized, Open-Label, Active-Comparator Controlled Study with a 6-Month Extension Phase | Zhang, Zhenlin; Liao, Er Yuan; Wei, Bo Xia; Lin, Hua; Wang, Li; Chen, De Cai; Tang, Hai; Hong, Wei; Hao, Yong Qiang; Peng, Yong De; He, Liang; Hu, Zhao Heng; Wei, Fang; Wang, Jue; Santora, Arthur |
| 2018 | Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D-3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal | Liao, Er-Yuan; Zhang, Zhen-Lin; Xia, Wei-Bo; Lin, Hua; Cheng, Qun; Wang, Li; Hao, Yong-Qiang; Chen, De-Cai; Tang, Hai; Peng, Yong-De; You, Li; He, Liang; Hu, Zhao-Heng; Song, Chun-Li; Wei, Fang; Wang, Jue; Zhang, Lei |
| 2018 | Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China | Liao, Er-Yuan; Zhang, Zhen-Lin; Xia, Wei-Bo; Lin, Hua; Cheng, Qun; Wang, Li; Hao, Yong-Qiang; Chen, De-Cai; Tang, Hai; Peng, Yong-De; You, Li; He, Liang; Hu, Zhao-Heng; Song, Chun-Li; Wei, Fang; Wang, Jue; Zhang, Lei |
| 2014 | Response in Subgroups based on Baseline 25-Hydroxyvitamin D and Bone Turnover Markers: Alendronate Sodium/Vitamin D-3 versus Calcitriol for Treatment of Osteoporosis in Chinese Women. | Zhang, Zhen Lin; Liao, Er Yuan; Xia, Weibo; Lin, Hua; Cheng, Qun; Wang, Li; Hao, Yong Qiang; Chen, De Cai; Tang, Hai; Peng, Yong De; You, Li; He, Liang; Hu, Zhao Heng; Song, Chun Li; Wei, Fang; Wang, Jue; Zhang, Lei; Santora, Arthur |
